The EMT spectrum and therapeutic opportunities

por Voon, Dominic C., Huang, Ruby Y., Jackson, Rebecca A., Thiery, Jean P.
Publicado 2017

Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma

por Deb, Barnali, Puttamallesh, Vinuth N., Gondkar, Kirti, Thiery, Jean P., Gowda, Harsha, Kumar, Prashant
Publicado 2019

Molecular characterization of breast cancer CTCs associated with brain metastasis

por Boral, Debasish, Vishnoi, Monika, Liu, Haowen N., Yin, Wei, Sprouse, Marc L., Scamardo, Antonio, Hong, David S., Tan, Tuan Z., Thiery, Jean P., Chang, Jenny C., Marchetti, Dario
Publicado 2017

‘Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin

por Abu-Tayeh, Hanan, Weidenfeld, Keren, Zhilin-Roth, Alisa, Schif-Zuck, Sagi, Thaler, Sonja, Cotarelo, Cristina, Tan, Tuan Z, Thiery, Jean P, Green, Jeffrey E, Klorin, Geula, Sabo, Edmond, Sleeman, Jonathan P, Tzukerman, Maty, Barkan, Dalit
Publicado 2016

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

por Røsland, Gro V., Dyrstad, Sissel E., Tusubira, Deusdedit, Helwa, Reham, Tan, Tuan Zea, Lotsberg, Maria L., Pettersen, Ina K. N., Berg, Anna, Kindt, Charlotte, Hoel, Fredrik, Jacobsen, Kirstine, Arason, Ari J., Engelsen, Agnete S. T., Ditzel, Henrik J., Lønning, Per E., Krakstad, Camilla, Thiery, Jean P., Lorens, James B., Knappskog, Stian, Tronstad, Karl J.
Publicado 2019